4D-310
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 4D-310, covering 2024-04-08 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: 4D-310 in Adults With Fabry Disease and Cardiac Involvement [Phase 1, Phase 2]